Global SPECT and PET Radiopharmaceuticals Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our (LP Info Research) latest study, the global SPECT and PET Radiopharmaceuticals market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the SPECT and PET Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global SPECT and PET Radiopharmaceuticals market. With recovery from influence of COVID-19 and the Russia-Ukraine War, SPECT and PET Radiopharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of SPECT and PET Radiopharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the SPECT and PET Radiopharmaceuticals market.
Key Features:
The report on SPECT and PET Radiopharmaceuticals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the SPECT and PET Radiopharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals, Positron Emission Tomography (PET) Radiopharmaceuticals), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the SPECT and PET Radiopharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the SPECT and PET Radiopharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the SPECT and PET Radiopharmaceuticals industry. This include advancements in SPECT and PET Radiopharmaceuticals technology, SPECT and PET Radiopharmaceuticals new entrants, SPECT and PET Radiopharmaceuticals new investment, and other innovations that are shaping the future of SPECT and PET Radiopharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the SPECT and PET Radiopharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for SPECT and PET Radiopharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the SPECT and PET Radiopharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting SPECT and PET Radiopharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the SPECT and PET Radiopharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the SPECT and PET Radiopharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the SPECT and PET Radiopharmaceuticals market.
Market Segmentation:
SPECT and PET Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our (LP Info Research) latest study, the global SPECT and PET Radiopharmaceuticals market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the SPECT and PET Radiopharmaceuticals is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global SPECT and PET Radiopharmaceuticals market. With recovery from influence of COVID-19 and the Russia-Ukraine War, SPECT and PET Radiopharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of SPECT and PET Radiopharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the SPECT and PET Radiopharmaceuticals market.
Key Features:
The report on SPECT and PET Radiopharmaceuticals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the SPECT and PET Radiopharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals, Positron Emission Tomography (PET) Radiopharmaceuticals), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the SPECT and PET Radiopharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the SPECT and PET Radiopharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the SPECT and PET Radiopharmaceuticals industry. This include advancements in SPECT and PET Radiopharmaceuticals technology, SPECT and PET Radiopharmaceuticals new entrants, SPECT and PET Radiopharmaceuticals new investment, and other innovations that are shaping the future of SPECT and PET Radiopharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the SPECT and PET Radiopharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for SPECT and PET Radiopharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the SPECT and PET Radiopharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting SPECT and PET Radiopharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the SPECT and PET Radiopharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the SPECT and PET Radiopharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the SPECT and PET Radiopharmaceuticals market.
Market Segmentation:
SPECT and PET Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
- Positron Emission Tomography (PET) Radiopharmaceuticals
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE Healthcare
- Cardinal Health
- Curium Pharma
- China Isotope & Radiation
- Jubilant Life Sciences
- Bracco
- Yantai Dongcheng Pharmaceutical
- Lantheus Medical Imaging, Inc.
- Eczac?baє? Monrol Nuclear Products
- Novartis International AG
- Siemens
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global SPECT and PET Radiopharmaceuticals Market Size 2018-2029
2.1.2 SPECT and PET Radiopharmaceuticals Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 SPECT and PET Radiopharmaceuticals Segment by Type
2.2.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
2.2.2 Positron Emission Tomography (PET) Radiopharmaceuticals
2.3 SPECT and PET Radiopharmaceuticals Market Size by Type
2.3.1 SPECT and PET Radiopharmaceuticals Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
2.4 SPECT and PET Radiopharmaceuticals Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 SPECT and PET Radiopharmaceuticals Market Size by Application
2.5.1 SPECT and PET Radiopharmaceuticals Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
3 SPECT AND PET RADIOPHARMACEUTICALS MARKET SIZE BY PLAYER
3.1 SPECT and PET Radiopharmaceuticals Market Size Market Share by Players
3.1.1 Global SPECT and PET Radiopharmaceuticals Revenue by Players (2018-2023)
3.1.2 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Players (2018-2023)
3.2 Global SPECT and PET Radiopharmaceuticals Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SPECT AND PET RADIOPHARMACEUTICALS BY REGIONS
4.1 SPECT and PET Radiopharmaceuticals Market Size by Regions (2018-2023)
4.2 Americas SPECT and PET Radiopharmaceuticals Market Size Growth (2018-2023)
4.3 APAC SPECT and PET Radiopharmaceuticals Market Size Growth (2018-2023)
4.4 Europe SPECT and PET Radiopharmaceuticals Market Size Growth (2018-2023)
4.5 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2023)
5.2 Americas SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
5.3 Americas SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2023)
6.2 APAC SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
6.3 APAC SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe SPECT and PET Radiopharmaceuticals by Country (2018-2023)
7.2 Europe SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
7.3 Europe SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa SPECT and PET Radiopharmaceuticals by Region (2018-2023)
8.2 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
8.3 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SPECT AND PET RADIOPHARMACEUTICALS MARKET FORECAST
10.1 Global SPECT and PET Radiopharmaceuticals Forecast by Regions (2024-2029)
10.1.1 Global SPECT and PET Radiopharmaceuticals Forecast by Regions (2024-2029)
10.1.2 Americas SPECT and PET Radiopharmaceuticals Forecast
10.1.3 APAC SPECT and PET Radiopharmaceuticals Forecast
10.1.4 Europe SPECT and PET Radiopharmaceuticals Forecast
10.1.5 Middle East & Africa SPECT and PET Radiopharmaceuticals Forecast
10.2 Americas SPECT and PET Radiopharmaceuticals Forecast by Country (2024-2029)
10.2.1 United States SPECT and PET Radiopharmaceuticals Market Forecast
10.2.2 Canada SPECT and PET Radiopharmaceuticals Market Forecast
10.2.3 Mexico SPECT and PET Radiopharmaceuticals Market Forecast
10.2.4 Brazil SPECT and PET Radiopharmaceuticals Market Forecast
10.3 APAC SPECT and PET Radiopharmaceuticals Forecast by Region (2024-2029)
10.3.1 China SPECT and PET Radiopharmaceuticals Market Forecast
10.3.2 Japan SPECT and PET Radiopharmaceuticals Market Forecast
10.3.3 Korea SPECT and PET Radiopharmaceuticals Market Forecast
10.3.4 Southeast Asia SPECT and PET Radiopharmaceuticals Market Forecast
10.3.5 India SPECT and PET Radiopharmaceuticals Market Forecast
10.3.6 Australia SPECT and PET Radiopharmaceuticals Market Forecast
10.4 Europe SPECT and PET Radiopharmaceuticals Forecast by Country (2024-2029)
10.4.1 Germany SPECT and PET Radiopharmaceuticals Market Forecast
10.4.2 France SPECT and PET Radiopharmaceuticals Market Forecast
10.4.3 UK SPECT and PET Radiopharmaceuticals Market Forecast
10.4.4 Italy SPECT and PET Radiopharmaceuticals Market Forecast
10.4.5 Russia SPECT and PET Radiopharmaceuticals Market Forecast
10.5 Middle East & Africa SPECT and PET Radiopharmaceuticals Forecast by Region (2024-2029)
10.5.1 Egypt SPECT and PET Radiopharmaceuticals Market Forecast
10.5.2 South Africa SPECT and PET Radiopharmaceuticals Market Forecast
10.5.3 Israel SPECT and PET Radiopharmaceuticals Market Forecast
10.5.4 Turkey SPECT and PET Radiopharmaceuticals Market Forecast
10.5.5 GCC Countries SPECT and PET Radiopharmaceuticals Market Forecast
10.6 Global SPECT and PET Radiopharmaceuticals Forecast by Type (2024-2029)
10.7 Global SPECT and PET Radiopharmaceuticals Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare SPECT and PET Radiopharmaceuticals Product Offered
11.1.3 GE Healthcare SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GE Healthcare Main Business Overview
11.1.5 GE Healthcare Latest Developments
11.2 Cardinal Health
11.2.1 Cardinal Health Company Information
11.2.2 Cardinal Health SPECT and PET Radiopharmaceuticals Product Offered
11.2.3 Cardinal Health SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cardinal Health Main Business Overview
11.2.5 Cardinal Health Latest Developments
11.3 Curium Pharma
11.3.1 Curium Pharma Company Information
11.3.2 Curium Pharma SPECT and PET Radiopharmaceuticals Product Offered
11.3.3 Curium Pharma SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Curium Pharma Main Business Overview
11.3.5 Curium Pharma Latest Developments
11.4 China Isotope & Radiation
11.4.1 China Isotope & Radiation Company Information
11.4.2 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Offered
11.4.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 China Isotope & Radiation Main Business Overview
11.4.5 China Isotope & Radiation Latest Developments
11.5 Jubilant Life Sciences
11.5.1 Jubilant Life Sciences Company Information
11.5.2 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product Offered
11.5.3 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Jubilant Life Sciences Main Business Overview
11.5.5 Jubilant Life Sciences Latest Developments
11.6 Bracco
11.6.1 Bracco Company Information
11.6.2 Bracco SPECT and PET Radiopharmaceuticals Product Offered
11.6.3 Bracco SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bracco Main Business Overview
11.6.5 Bracco Latest Developments
11.7 Yantai Dongcheng Pharmaceutical
11.7.1 Yantai Dongcheng Pharmaceutical Company Information
11.7.2 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product Offered
11.7.3 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Yantai Dongcheng Pharmaceutical Main Business Overview
11.7.5 Yantai Dongcheng Pharmaceutical Latest Developments
11.8 Lantheus Medical Imaging, Inc.
11.8.1 Lantheus Medical Imaging, Inc. Company Information
11.8.2 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product Offered
11.8.3 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Lantheus Medical Imaging, Inc. Main Business Overview
11.8.5 Lantheus Medical Imaging, Inc. Latest Developments
11.9 Eczac?baє? Monrol Nuclear Products
11.9.1 Eczac?baє? Monrol Nuclear Products Company Information
11.9.2 Eczac?baє? Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product Offered
11.9.3 Eczac?baє? Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Eczac?baє? Monrol Nuclear Products Main Business Overview
11.9.5 Eczac?baє? Monrol Nuclear Products Latest Developments
11.10 Novartis International AG
11.10.1 Novartis International AG Company Information
11.10.2 Novartis International AG SPECT and PET Radiopharmaceuticals Product Offered
11.10.3 Novartis International AG SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Novartis International AG Main Business Overview
11.10.5 Novartis International AG Latest Developments
11.11 Siemens
11.11.1 Siemens Company Information
11.11.2 Siemens SPECT and PET Radiopharmaceuticals Product Offered
11.11.3 Siemens SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Siemens Main Business Overview
11.11.5 Siemens Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global SPECT and PET Radiopharmaceuticals Market Size 2018-2029
2.1.2 SPECT and PET Radiopharmaceuticals Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 SPECT and PET Radiopharmaceuticals Segment by Type
2.2.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
2.2.2 Positron Emission Tomography (PET) Radiopharmaceuticals
2.3 SPECT and PET Radiopharmaceuticals Market Size by Type
2.3.1 SPECT and PET Radiopharmaceuticals Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
2.4 SPECT and PET Radiopharmaceuticals Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 SPECT and PET Radiopharmaceuticals Market Size by Application
2.5.1 SPECT and PET Radiopharmaceuticals Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
3 SPECT AND PET RADIOPHARMACEUTICALS MARKET SIZE BY PLAYER
3.1 SPECT and PET Radiopharmaceuticals Market Size Market Share by Players
3.1.1 Global SPECT and PET Radiopharmaceuticals Revenue by Players (2018-2023)
3.1.2 Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Players (2018-2023)
3.2 Global SPECT and PET Radiopharmaceuticals Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SPECT AND PET RADIOPHARMACEUTICALS BY REGIONS
4.1 SPECT and PET Radiopharmaceuticals Market Size by Regions (2018-2023)
4.2 Americas SPECT and PET Radiopharmaceuticals Market Size Growth (2018-2023)
4.3 APAC SPECT and PET Radiopharmaceuticals Market Size Growth (2018-2023)
4.4 Europe SPECT and PET Radiopharmaceuticals Market Size Growth (2018-2023)
4.5 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2023)
5.2 Americas SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
5.3 Americas SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2023)
6.2 APAC SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
6.3 APAC SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe SPECT and PET Radiopharmaceuticals by Country (2018-2023)
7.2 Europe SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
7.3 Europe SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa SPECT and PET Radiopharmaceuticals by Region (2018-2023)
8.2 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023)
8.3 Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SPECT AND PET RADIOPHARMACEUTICALS MARKET FORECAST
10.1 Global SPECT and PET Radiopharmaceuticals Forecast by Regions (2024-2029)
10.1.1 Global SPECT and PET Radiopharmaceuticals Forecast by Regions (2024-2029)
10.1.2 Americas SPECT and PET Radiopharmaceuticals Forecast
10.1.3 APAC SPECT and PET Radiopharmaceuticals Forecast
10.1.4 Europe SPECT and PET Radiopharmaceuticals Forecast
10.1.5 Middle East & Africa SPECT and PET Radiopharmaceuticals Forecast
10.2 Americas SPECT and PET Radiopharmaceuticals Forecast by Country (2024-2029)
10.2.1 United States SPECT and PET Radiopharmaceuticals Market Forecast
10.2.2 Canada SPECT and PET Radiopharmaceuticals Market Forecast
10.2.3 Mexico SPECT and PET Radiopharmaceuticals Market Forecast
10.2.4 Brazil SPECT and PET Radiopharmaceuticals Market Forecast
10.3 APAC SPECT and PET Radiopharmaceuticals Forecast by Region (2024-2029)
10.3.1 China SPECT and PET Radiopharmaceuticals Market Forecast
10.3.2 Japan SPECT and PET Radiopharmaceuticals Market Forecast
10.3.3 Korea SPECT and PET Radiopharmaceuticals Market Forecast
10.3.4 Southeast Asia SPECT and PET Radiopharmaceuticals Market Forecast
10.3.5 India SPECT and PET Radiopharmaceuticals Market Forecast
10.3.6 Australia SPECT and PET Radiopharmaceuticals Market Forecast
10.4 Europe SPECT and PET Radiopharmaceuticals Forecast by Country (2024-2029)
10.4.1 Germany SPECT and PET Radiopharmaceuticals Market Forecast
10.4.2 France SPECT and PET Radiopharmaceuticals Market Forecast
10.4.3 UK SPECT and PET Radiopharmaceuticals Market Forecast
10.4.4 Italy SPECT and PET Radiopharmaceuticals Market Forecast
10.4.5 Russia SPECT and PET Radiopharmaceuticals Market Forecast
10.5 Middle East & Africa SPECT and PET Radiopharmaceuticals Forecast by Region (2024-2029)
10.5.1 Egypt SPECT and PET Radiopharmaceuticals Market Forecast
10.5.2 South Africa SPECT and PET Radiopharmaceuticals Market Forecast
10.5.3 Israel SPECT and PET Radiopharmaceuticals Market Forecast
10.5.4 Turkey SPECT and PET Radiopharmaceuticals Market Forecast
10.5.5 GCC Countries SPECT and PET Radiopharmaceuticals Market Forecast
10.6 Global SPECT and PET Radiopharmaceuticals Forecast by Type (2024-2029)
10.7 Global SPECT and PET Radiopharmaceuticals Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare SPECT and PET Radiopharmaceuticals Product Offered
11.1.3 GE Healthcare SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GE Healthcare Main Business Overview
11.1.5 GE Healthcare Latest Developments
11.2 Cardinal Health
11.2.1 Cardinal Health Company Information
11.2.2 Cardinal Health SPECT and PET Radiopharmaceuticals Product Offered
11.2.3 Cardinal Health SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Cardinal Health Main Business Overview
11.2.5 Cardinal Health Latest Developments
11.3 Curium Pharma
11.3.1 Curium Pharma Company Information
11.3.2 Curium Pharma SPECT and PET Radiopharmaceuticals Product Offered
11.3.3 Curium Pharma SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Curium Pharma Main Business Overview
11.3.5 Curium Pharma Latest Developments
11.4 China Isotope & Radiation
11.4.1 China Isotope & Radiation Company Information
11.4.2 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Offered
11.4.3 China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 China Isotope & Radiation Main Business Overview
11.4.5 China Isotope & Radiation Latest Developments
11.5 Jubilant Life Sciences
11.5.1 Jubilant Life Sciences Company Information
11.5.2 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product Offered
11.5.3 Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Jubilant Life Sciences Main Business Overview
11.5.5 Jubilant Life Sciences Latest Developments
11.6 Bracco
11.6.1 Bracco Company Information
11.6.2 Bracco SPECT and PET Radiopharmaceuticals Product Offered
11.6.3 Bracco SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bracco Main Business Overview
11.6.5 Bracco Latest Developments
11.7 Yantai Dongcheng Pharmaceutical
11.7.1 Yantai Dongcheng Pharmaceutical Company Information
11.7.2 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product Offered
11.7.3 Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Yantai Dongcheng Pharmaceutical Main Business Overview
11.7.5 Yantai Dongcheng Pharmaceutical Latest Developments
11.8 Lantheus Medical Imaging, Inc.
11.8.1 Lantheus Medical Imaging, Inc. Company Information
11.8.2 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product Offered
11.8.3 Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Lantheus Medical Imaging, Inc. Main Business Overview
11.8.5 Lantheus Medical Imaging, Inc. Latest Developments
11.9 Eczac?baє? Monrol Nuclear Products
11.9.1 Eczac?baє? Monrol Nuclear Products Company Information
11.9.2 Eczac?baє? Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product Offered
11.9.3 Eczac?baє? Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Eczac?baє? Monrol Nuclear Products Main Business Overview
11.9.5 Eczac?baє? Monrol Nuclear Products Latest Developments
11.10 Novartis International AG
11.10.1 Novartis International AG Company Information
11.10.2 Novartis International AG SPECT and PET Radiopharmaceuticals Product Offered
11.10.3 Novartis International AG SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Novartis International AG Main Business Overview
11.10.5 Novartis International AG Latest Developments
11.11 Siemens
11.11.1 Siemens Company Information
11.11.2 Siemens SPECT and PET Radiopharmaceuticals Product Offered
11.11.3 Siemens SPECT and PET Radiopharmaceuticals Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Siemens Main Business Overview
11.11.5 Siemens Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. SPECT and PET Radiopharmaceuticals Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
Table 3. Major Players of Positron Emission Tomography (PET) Radiopharmaceuticals
Table 4. SPECT and PET Radiopharmaceuticals Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 7. SPECT and PET Radiopharmaceuticals Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 10. Global SPECT and PET Radiopharmaceuticals Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Player (2018-2023)
Table 12. SPECT and PET Radiopharmaceuticals Key Players Head office and Products Offered
Table 13. SPECT and PET Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global SPECT and PET Radiopharmaceuticals Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Regions (2018-2023)
Table 18. Global SPECT and PET Radiopharmaceuticals Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas SPECT and PET Radiopharmaceuticals Market Size Market Share by Country (2018-2023)
Table 22. Americas SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 24. Americas SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 26. APAC SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Table 28. APAC SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 30. APAC SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 32. Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Country (2018-2023)
Table 34. Europe SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 36. Europe SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of SPECT and PET Radiopharmaceuticals
Table 45. Key Market Challenges & Risks of SPECT and PET Radiopharmaceuticals
Table 46. Key Industry Trends of SPECT and PET Radiopharmaceuticals
Table 47. Global SPECT and PET Radiopharmaceuticals Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global SPECT and PET Radiopharmaceuticals Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global SPECT and PET Radiopharmaceuticals Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global SPECT and PET Radiopharmaceuticals Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. GE Healthcare Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 52. GE Healthcare SPECT and PET Radiopharmaceuticals Product Offered
Table 53. GE Healthcare SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. GE Healthcare Main Business
Table 55. GE Healthcare Latest Developments
Table 56. Cardinal Health Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 57. Cardinal Health SPECT and PET Radiopharmaceuticals Product Offered
Table 58. Cardinal Health Main Business
Table 59. Cardinal Health SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Cardinal Health Latest Developments
Table 61. Curium Pharma Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 62. Curium Pharma SPECT and PET Radiopharmaceuticals Product Offered
Table 63. Curium Pharma Main Business
Table 64. Curium Pharma SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Curium Pharma Latest Developments
Table 66. China Isotope & Radiation Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 67. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Offered
Table 68. China Isotope & Radiation Main Business
Table 69. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. China Isotope & Radiation Latest Developments
Table 71. Jubilant Life Sciences Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 72. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product Offered
Table 73. Jubilant Life Sciences Main Business
Table 74. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Jubilant Life Sciences Latest Developments
Table 76. Bracco Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 77. Bracco SPECT and PET Radiopharmaceuticals Product Offered
Table 78. Bracco Main Business
Table 79. Bracco SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Bracco Latest Developments
Table 81. Yantai Dongcheng Pharmaceutical Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 82. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product Offered
Table 83. Yantai Dongcheng Pharmaceutical Main Business
Table 84. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Yantai Dongcheng Pharmaceutical Latest Developments
Table 86. Lantheus Medical Imaging, Inc. Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 87. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product Offered
Table 88. Lantheus Medical Imaging, Inc. Main Business
Table 89. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Lantheus Medical Imaging, Inc. Latest Developments
Table 91. Eczac?baє? Monrol Nuclear Products Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 92. Eczac?baє? Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product Offered
Table 93. Eczac?baє? Monrol Nuclear Products Main Business
Table 94. Eczac?baє? Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Eczac?baє? Monrol Nuclear Products Latest Developments
Table 96. Novartis International AG Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 97. Novartis International AG SPECT and PET Radiopharmaceuticals Product Offered
Table 98. Novartis International AG Main Business
Table 99. Novartis International AG SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Novartis International AG Latest Developments
Table 101. Siemens Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 102. Siemens SPECT and PET Radiopharmaceuticals Product Offered
Table 103. Siemens SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Siemens Main Business
Table 105. Siemens Latest Developments
Table 1. SPECT and PET Radiopharmaceuticals Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
Table 3. Major Players of Positron Emission Tomography (PET) Radiopharmaceuticals
Table 4. SPECT and PET Radiopharmaceuticals Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 7. SPECT and PET Radiopharmaceuticals Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 10. Global SPECT and PET Radiopharmaceuticals Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Player (2018-2023)
Table 12. SPECT and PET Radiopharmaceuticals Key Players Head office and Products Offered
Table 13. SPECT and PET Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global SPECT and PET Radiopharmaceuticals Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Regions (2018-2023)
Table 18. Global SPECT and PET Radiopharmaceuticals Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas SPECT and PET Radiopharmaceuticals Market Size Market Share by Country (2018-2023)
Table 22. Americas SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 24. Americas SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 26. APAC SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Table 28. APAC SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 30. APAC SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 32. Europe SPECT and PET Radiopharmaceuticals Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Country (2018-2023)
Table 34. Europe SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 36. Europe SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of SPECT and PET Radiopharmaceuticals
Table 45. Key Market Challenges & Risks of SPECT and PET Radiopharmaceuticals
Table 46. Key Industry Trends of SPECT and PET Radiopharmaceuticals
Table 47. Global SPECT and PET Radiopharmaceuticals Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global SPECT and PET Radiopharmaceuticals Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global SPECT and PET Radiopharmaceuticals Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global SPECT and PET Radiopharmaceuticals Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. GE Healthcare Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 52. GE Healthcare SPECT and PET Radiopharmaceuticals Product Offered
Table 53. GE Healthcare SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. GE Healthcare Main Business
Table 55. GE Healthcare Latest Developments
Table 56. Cardinal Health Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 57. Cardinal Health SPECT and PET Radiopharmaceuticals Product Offered
Table 58. Cardinal Health Main Business
Table 59. Cardinal Health SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Cardinal Health Latest Developments
Table 61. Curium Pharma Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 62. Curium Pharma SPECT and PET Radiopharmaceuticals Product Offered
Table 63. Curium Pharma Main Business
Table 64. Curium Pharma SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Curium Pharma Latest Developments
Table 66. China Isotope & Radiation Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 67. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Product Offered
Table 68. China Isotope & Radiation Main Business
Table 69. China Isotope & Radiation SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. China Isotope & Radiation Latest Developments
Table 71. Jubilant Life Sciences Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 72. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Product Offered
Table 73. Jubilant Life Sciences Main Business
Table 74. Jubilant Life Sciences SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Jubilant Life Sciences Latest Developments
Table 76. Bracco Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 77. Bracco SPECT and PET Radiopharmaceuticals Product Offered
Table 78. Bracco Main Business
Table 79. Bracco SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Bracco Latest Developments
Table 81. Yantai Dongcheng Pharmaceutical Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 82. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Product Offered
Table 83. Yantai Dongcheng Pharmaceutical Main Business
Table 84. Yantai Dongcheng Pharmaceutical SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Yantai Dongcheng Pharmaceutical Latest Developments
Table 86. Lantheus Medical Imaging, Inc. Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 87. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Product Offered
Table 88. Lantheus Medical Imaging, Inc. Main Business
Table 89. Lantheus Medical Imaging, Inc. SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Lantheus Medical Imaging, Inc. Latest Developments
Table 91. Eczac?baє? Monrol Nuclear Products Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 92. Eczac?baє? Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Product Offered
Table 93. Eczac?baє? Monrol Nuclear Products Main Business
Table 94. Eczac?baє? Monrol Nuclear Products SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Eczac?baє? Monrol Nuclear Products Latest Developments
Table 96. Novartis International AG Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 97. Novartis International AG SPECT and PET Radiopharmaceuticals Product Offered
Table 98. Novartis International AG Main Business
Table 99. Novartis International AG SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Novartis International AG Latest Developments
Table 101. Siemens Details, Company Type, SPECT and PET Radiopharmaceuticals Area Served and Its Competitors
Table 102. Siemens SPECT and PET Radiopharmaceuticals Product Offered
Table 103. Siemens SPECT and PET Radiopharmaceuticals Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Siemens Main Business
Table 105. Siemens Latest Developments
LIST OF FIGURES
Figure 1. SPECT and PET Radiopharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global SPECT and PET Radiopharmaceuticals Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. SPECT and PET Radiopharmaceuticals Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. SPECT and PET Radiopharmaceuticals Sales Market Share by Country/Region (2022)
Figure 8. SPECT and PET Radiopharmaceuticals Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Type in 2022
Figure 10. SPECT and PET Radiopharmaceuticals in Hospitals
Figure 11. Global SPECT and PET Radiopharmaceuticals Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. SPECT and PET Radiopharmaceuticals in Clinics
Figure 13. Global SPECT and PET Radiopharmaceuticals Market: Clinics (2018-2023) & ($ Millions)
Figure 14. SPECT and PET Radiopharmaceuticals in Others
Figure 15. Global SPECT and PET Radiopharmaceuticals Market: Others (2018-2023) & ($ Millions)
Figure 16. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Application in 2022
Figure 17. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Player in 2022
Figure 18. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Regions (2018-2023)
Figure 19. Americas SPECT and PET Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 20. APAC SPECT and PET Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 21. Europe SPECT and PET Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 23. Americas SPECT and PET Radiopharmaceuticals Value Market Share by Country in 2022
Figure 24. United States SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Region in 2022
Figure 29. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Type in 2022
Figure 30. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Application in 2022
Figure 31. China SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 35. India SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Country in 2022
Figure 38. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Figure 39. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Figure 40. Germany SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 41. France SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Figure 48. Egypt SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 54. APAC SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 55. Europe SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 57. United States SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 58. Canada SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 59. Mexico SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 60. Brazil SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 61. China SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 62. Japan SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 63. Korea SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 65. India SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 66. Australia SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 67. Germany SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 68. France SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 69. UK SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 70. Italy SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 71. Russia SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 72. Spain SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 73. Egypt SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 74. South Africa SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 75. Israel SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 76. Turkey SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 78. Global SPECT and PET Radiopharmaceuticals Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global SPECT and PET Radiopharmaceuticals Market Size Market Share Forecast by Application (2024-2029)
Figure 1. SPECT and PET Radiopharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global SPECT and PET Radiopharmaceuticals Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. SPECT and PET Radiopharmaceuticals Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. SPECT and PET Radiopharmaceuticals Sales Market Share by Country/Region (2022)
Figure 8. SPECT and PET Radiopharmaceuticals Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Type in 2022
Figure 10. SPECT and PET Radiopharmaceuticals in Hospitals
Figure 11. Global SPECT and PET Radiopharmaceuticals Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. SPECT and PET Radiopharmaceuticals in Clinics
Figure 13. Global SPECT and PET Radiopharmaceuticals Market: Clinics (2018-2023) & ($ Millions)
Figure 14. SPECT and PET Radiopharmaceuticals in Others
Figure 15. Global SPECT and PET Radiopharmaceuticals Market: Others (2018-2023) & ($ Millions)
Figure 16. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Application in 2022
Figure 17. Global SPECT and PET Radiopharmaceuticals Revenue Market Share by Player in 2022
Figure 18. Global SPECT and PET Radiopharmaceuticals Market Size Market Share by Regions (2018-2023)
Figure 19. Americas SPECT and PET Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 20. APAC SPECT and PET Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 21. Europe SPECT and PET Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size 2018-2023 ($ Millions)
Figure 23. Americas SPECT and PET Radiopharmaceuticals Value Market Share by Country in 2022
Figure 24. United States SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Region in 2022
Figure 29. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Type in 2022
Figure 30. APAC SPECT and PET Radiopharmaceuticals Market Size Market Share by Application in 2022
Figure 31. China SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 35. India SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Country in 2022
Figure 38. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Figure 39. Europe SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Figure 40. Germany SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 41. France SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size Market Share by Application (2018-2023)
Figure 48. Egypt SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country SPECT and PET Radiopharmaceuticals Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 54. APAC SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 55. Europe SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 57. United States SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 58. Canada SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 59. Mexico SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 60. Brazil SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 61. China SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 62. Japan SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 63. Korea SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 65. India SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 66. Australia SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 67. Germany SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 68. France SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 69. UK SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 70. Italy SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 71. Russia SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 72. Spain SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 73. Egypt SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 74. South Africa SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 75. Israel SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 76. Turkey SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries SPECT and PET Radiopharmaceuticals Market Size 2024-2029 ($ Millions)
Figure 78. Global SPECT and PET Radiopharmaceuticals Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global SPECT and PET Radiopharmaceuticals Market Size Market Share Forecast by Application (2024-2029)
